And I still think Elto has a good chance of ending up with ac immune. It's the perfect size company to partner with us, Dr. Lowe is there and is done with his existing project this fall, and they just announced a raise of approx $130m this week. Notice how they introduce themselves, "a swiss based clinical stage biopharmaceutical company focused on neurodegenerative diseases "
http://cws.huginonline.com/A/171580/PR/201807/2205787_5.html